Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2005
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688307A 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments
10/25/2005US6958384 Polypeptides containing γ-amino acids
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958205 Image forming material and ammonium compound
10/25/2005US6958176 Liquid crystal mixture
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2266468C Preparation of 1-butyl-4-piperidinylmethylamine
10/25/2005CA2261725C Piperidine and piperazine derivatives and their use as muscarinic antagonists
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097779A1 Diarylamine derivatives as calcium channel blockers
10/20/2005WO2005097775A1 Piperidine derivates for the treatment of chemokines mediared disease
10/20/2005WO2005097768A2 Novel gamma secretase inhibitors
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005WO2005097118A1 Aldosterone receptor antagonists
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005WO2004103289A3 Driverse thyroid hormone receptor antagonists and uses thereof
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234057 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050234044 Cyclic amine derivatives and methods of use
10/20/2005US20050231490 Thin display device
10/20/2005CA2563033A1 Novel gamma secretase inhibitors
10/20/2005CA2562371A1 Diarylamine derivatives as calcium channel blockers
10/20/2005CA2561967A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
10/19/2005EP1586561A1 Bicyclic aromatic sulfinyl derivatives
10/19/2005EP1586560A1 Thio-substituted arylmethanesulfinyl derivatives
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586556A2 Compounds to treat Alzheimer's disease
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1585729A1 2-piperidone derivatives as prostaglandin agonists
10/19/2005EP1585515A2 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor
10/19/2005EP1432683B1 Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation
10/19/2005EP1423373B1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
10/19/2005EP1240142B1 New modulators of dopamine neurotransmission
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956988 Optical interleaver
10/18/2005US6956046 4-hydroxypiperidine derivatives having analgesic activity
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005CA2329075C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2211934C 2-phenyl-2-(2'-piperidinylidene)acetate derivative, process for manufacturing the same, and process for manufacturing optically active 2-phenyl-2-(2'-piperidinyl)acetate derivative by asymmetrically hydrogenating the same
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/13/2005WO2005095385A1 Process for the preparation of tryptase inhibitors
10/13/2005WO2005095350A1 Pyrazole compounds and uses related thereto
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094896A2 Targeted serotonin reuptake inhibitors
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2005033288A3 Hedgehog pathway antagonists
10/13/2005WO2005023183A3 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
10/13/2005US20050228180 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050228023 Agonist and antagonist ligands of the nociceptin receptor
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227969 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction
10/13/2005US20050227955 Reduction of the benzoquinone moiety to form a hydroquinone, and salt formation, producing 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents
10/13/2005US20050227076 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/13/2005DE102004015095A1 Use of N-(cyclo)alkylpyrrolidones in the production of polyurethanes useful for preparing polyurethane dispersions
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2559945A1 Pyrazole compounds and uses related thereto
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005EP1001772B1 Improved delivery of multiple doses of medications
10/12/2005CN1681830A Novel chemical substance having morphogenetic and growth-accelerating activities
10/12/2005CN1681801A Quinolylpropylpiperidine derivatives and their use as anti-microorgans agent
10/12/2005CN1681786A Processes for the preparation of s-(-)-amlodipine
10/12/2005CN1681785A S-(-)-amlodipine nicotinate and process for the preparation thereof
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681504A N-sulfonylpiperidines as metalloproteinase inhibitors (TACE)
10/12/2005CN1681503A Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1679568A Use of n-substituted-1, 5-di deoxy-1, 5-imino-d-glucitol compounds for treating hepatitis virus infections
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953856 Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
10/11/2005US6953811 N-substituted tetrahydropyridines and their use as pesticides
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953789 a 3- or 4-Mercapto-1-(4-phenoxybenzyl)azepine-2-one; thioetherification with a mercaptan; matrix metalloprotease (MMP) inhibitors; antiarthritic, anticaries agent;
10/11/2005US6953606 For use as solvents e.g., in cleaning procedures such as dry cleaning, water removal and in coating; replacements for chlorinated chemicals , low global warming potentials
10/11/2005CA2275596C Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 380